Connor, Clark & Lunn Investment Management (CC&L)’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $1.34M | Buy |
|
|||||
|
2024
Q4 | $1.07M | Sell |
|
|||||
|
2024
Q3 | $1.44M | Sell |
|
|||||
|
2024
Q2 | $1.67M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $2.53M | Sell |
|
|||||
|
2022
Q3 | $3.8M | Buy |
|
|||||
|
2022
Q2 | $404K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $245K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $896K | Sell |
|
|||||
|
2019
Q1 | $1.67M | Sell |
|
|||||
|
2018
Q4 | $3.74M | Sell |
|
|||||
|
2018
Q3 | $6.78M | Sell |
|
|||||
|
2018
Q2 | $9.27M | Sell |
|
|||||
|
2018
Q1 | $14M | Buy |
|
|||||
|
2017
Q4 | $8.44M | Buy |
|
|||||
|
2017
Q3 | $8.58M | Buy |
|
|||||
|
2017
Q2 | $661K | Sell |
|
|||||
|
2017
Q1 | $717K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $717K | Sell |
|
|||||
|
2016
Q2 | $449K | Buy |
|
|||||
|
2016
Q1 | $84K | Sell |
|
|||||
|
2015
Q4 | $473K | Sell |
|
|||||
|
2015
Q3 | $702K | Sell |
|
|||||
|
2015
Q2 | $1.69M | Sell |
|
|||||
|
2015
Q1 | $2.22M | Buy |
|
|||||
|
2014
Q4 | $689K | Buy |
|